Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Mar 23

PMID 27002634

Citations 18

Authors

Yi Liao

Stuart Gilmour

Kenji Shibuya

Affiliations

Soon will be listed here.

Abstract

Background: China has rapidly expanded health insurance coverage over the past decade but its impact on hypertension control is not well known. We analyzed factors associated with hypertension and the impact of health insurance on the management of hypertension in China from 1991 to 2009.

Methods And Findings: We used individual-level data from the China Health and Nutrition Survey (CHNS) for blood pressure, BMI, and other socio-economic variables. We employed multi-level logistic regression models to estimate the factors associated with prevalence and management of hypertension. We also estimated the effects of health insurance on management of hypertension using propensity score matching. We found that prevalence of hypertension increased from 23.8% (95% CI: 22.5-25.1%) in 1991 to 31.5% (28.5-34.7%) in 2009. The proportion of hypertensive patients aware of their condition increased from 31.7% (28.7-34.9%) to 51.1% (45.1-57.0%). The proportion of diagnosed hypertensive patients in treatment increased by 35.5% in the 19 years, while the proportion of those in treatment with controlled blood pressure remained low. Among diagnosed hypertensives, health insurance increased the probability of receiving treatment by 28.7% (95% CI: 10.6-46.7%) compared to propensity-matched individuals not covered by health insurance.

Conclusions: Hypertension continues to be a major health threat in China and effective control has not improved over time despite large improvements in awareness and treatment access. This suggests problems in treatment quality, medication adherence and patient understanding of the condition. Improvements in hypertension management, quality of medical care for those at high risk, and better health insurance packages are needed.

Citing Articles

The impact of health insurance on hypertension care: a household fixed effects study in India.

Feng Z, Chen Q, Jiao L, Ma X, Atun R, Geldsetzer P BMC Public Health. 2024; 24(1):2287.

PMID: 39175008 PMC: 11342611. DOI: 10.1186/s12889-024-19759-1.

Trend and projection of non-communicable diseases risk factors in Iran from 2001 to 2030.

Farzadfar F, Yousefi M, Jafari-Khounigh A, Khorrami Z, Haghdoost A, Khosravi Shadmani F Sci Rep. 2024; 14(1):8092.

PMID: 38582931 PMC: 10998837. DOI: 10.1038/s41598-024-58629-z.

Adherence Behaviors and Related Factors Among Elderly Hypertensive Patients in China: Evidence from the China Health and Retirement Longitudinal Study.

Liu F, Chang H, Liu X Patient Prefer Adherence. 2023; 17:3539-3553.

PMID: 38152445 PMC: 10752232. DOI: 10.2147/PPA.S445789.

Knowledge and practices related to salt consumption in China: findings from a national representative cross-sectional survey.

Zhang W, Neupane D, Zhao Z, Jiang B, Zhang M, Zhang X J Hum Hypertens. 2023; 38(2):155-167.

PMID: 37857758 PMC: 10844095. DOI: 10.1038/s41371-023-00861-7.

Systematic literature review and meta-analysis of cardiovascular risk factor management in selected Asian countries.

Yeh E, Grigolon R, Rodrigues S, A Bueno A J Comp Eff Res. 2023; 12(4):e220085.

PMID: 36861459 PMC: 10402804. DOI: 10.57264/cer-2022-0085.

References

Li J, Liang X, Cao J, Zhu K, Deng Y, Zhou Z . [Current status and urban-rural comparison of clinical agency of detection, management, and health insurance for hypertensive patients in communities of five provinces in China in 2010]. Zhonghua Yu Fang Yi Xue Za Zhi. 2013; 47(4):301-5. View

Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M . Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008; 372(9642):940-9. DOI: 10.1016/S0140-6736(08)61404-X. View

Parry J . Nine in 10 Chinese are covered by medical insurance, but access to treatment remains a problem. BMJ. 2012; 344:e248. DOI: 10.1136/bmj.e248. View

Popkin B, Du S, Zhai F, Zhang B . Cohort Profile: The China Health and Nutrition Survey--monitoring and understanding socio-economic and health change in China, 1989-2011. Int J Epidemiol. 2009; 39(6):1435-40. PMC: 2992625. DOI: 10.1093/ije/dyp322. View

STAMLER R, Liu L, Nichols R, Huang D, Long Z, Xie J . Blood pressure and life style in the People's Republic of China: three samples in the INTERSALT Study. J Hum Hypertens. 1993; 7(5):429-35. View

Hagihara A, Murakami M, Chishaki A, Nabeshima F, Nobutomo K . Rate of health insurance reimbursement and adherence to anti-hypertensive treatment among Japanese patients. Health Policy. 2001; 58(3):231-42. DOI: 10.1016/s0168-8510(01)00171-3. View

Anderson C, Appel L, Okuda N, Brown I, Chan Q, Zhao L . Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010; 110(5):736-45. PMC: 4308093. DOI: 10.1016/j.jada.2010.02.007. View

Sun Q, Liu X, Meng Q, Tang S, Yu B, Tolhurst R . Evaluating the financial protection of patients with chronic disease by health insurance in rural China. Int J Equity Health. 2009; 8:42. PMC: 2799402. DOI: 10.1186/1475-9276-8-42. View

Black H, Elliott W, Neaton J, Grandits G, Grambsch P, Grimm Jr R . Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension. 2001; 37(1):12-18. DOI: 10.1161/01.hyp.37.1.12. View

10.

Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen L . Emergence of chronic non-communicable diseases in China. Lancet. 2008; 372(9650):1697-705. DOI: 10.1016/S0140-6736(08)61366-5. View

11.

Izzo Jr J, Levy D, Black H . Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension. 2000; 35(5):1021-4. DOI: 10.1161/01.hyp.35.5.1021. View

12.

Ma G, Li Y, Wu Y, Zhai F, Cui Z, Hu X . [The prevalence of body overweight and obesity and its changes among Chinese people during 1992 to 2002]. Zhonghua Yu Fang Yi Xue Za Zhi. 2005; 39(5):311-5. View

13.

Song Y, Ma W, Yi X, Wang S, Sun X, Tian J . Chronic diseases knowledge and related factors among the elderly in Jinan, China. PLoS One. 2013; 8(6):e68599. PMC: 3691150. DOI: 10.1371/journal.pone.0068599. View

14.

Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad A . Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014; 92(1):10-19C. PMC: 3865548. DOI: 10.2471/BLT.13.121954. View

15.

Ikeda N, Gakidou E, Hasegawa T, Murray C . Understanding the decline of mean systolic blood pressure in Japan: an analysis of pooled data from the National Nutrition Survey, 1986-2002. Bull World Health Organ. 2009; 86(12):978-88. PMC: 2649578. DOI: 10.2471/blt.07.050195. View

16.

Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J . Prevalence of hypertension in china: a cross-sectional study. PLoS One. 2013; 8(6):e65938. PMC: 3679057. DOI: 10.1371/journal.pone.0065938. View

17.

Kenrik Duru O, Vargas R, Kermah D, Pan D, Norris K . Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens. 2007; 20(4):348-53. DOI: 10.1016/j.amjhyper.2006.11.007. View

18.

Bramlage P, Bohm M, Volpe M, Khan B, Paar W, Tebbe U . A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich). 2010; 12(9):666-77. PMC: 8673112. DOI: 10.1111/j.1751-7176.2010.00322.x. View

19.

Yip W, Hsiao W . Non-evidence-based policy: how effective is China's new cooperative medical scheme in reducing medical impoverishment?. Soc Sci Med. 2008; 68(2):201-9. DOI: 10.1016/j.socscimed.2008.09.066. View

20.

Liu L . [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011; 39(7):579-615. View